Vigonvita Life Sciences
Registry sponsor category
Industry
- Other names
- Vigonvita Life Sciences
- Company name
- Vigonvita Life Sciences
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (36)
- A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV
- A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects
- A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
- A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension
- A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension
- A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension
- Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension
- Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
- Drug-Drug Interaction (DDI) Study for TPN171H
- Effect of TPN171H on Spermatogenesis
- Efficacy and Safety of JT001 (VV116) Compared With Paxlovid
- Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction
- Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
- Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers
- Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE
- Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
- Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
- Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers
- Long-term Safety of TPN171H Tablet in Erectile Dysfunction.